Viking Therapeutics, Inc. (NASDAQ:VKTX) Q1 2024 Earnings Call Transcript
Viking Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.26, expectations were $-0.27. Viking Therapeutics, Inc.
Viking Therapeutics Inc. (VKTX)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | CaaS Capital Frank Fu | 33,000 | $2,706,000 | 0.19% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.47 | 45,000 | Director | 111,250 | 2022-05-02 | Filing | |
| $5.69 | 20,000 | Director | 66,250 | 2021-06-10 | Filing | |
| $9.82 | 9,500 | Director | 9,500 | 2018-05-31 | Filing | |
| $5.16 | 30,000 | Director | 30,000 | 2018-05-29 | Filing | |
| $5.21 | 8,000 | Director | 8,000 | 2018-05-29 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $76.07 | 847 | Officer | 174,854 | 2024-05-03 | Filing | |
| $75.49 | 17,238 | Officer | 175,701 | 2024-05-03 | Filing | |
| $74.44 | 45,570 | Officer | 192,939 | 2024-05-03 | Filing | |
| $73.49 | 3,101 | Officer | 238,509 | 2024-05-03 | Filing | |
| $80.08 | 6,248 | Officer | 348,508 | 2024-05-01 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 15,004,340 | $279,230,768 | 0.02% | |
| 2. | 7,605,867 | $141,545,187 | 0% | |
| 3. | 5,732,990 | $106,690,944 | 0% | |
| 4. | 5,381,904 | $100,157,234 | 0% | |
| 5. | 3,673,935 | $68,371,930 | 0.02% |
News See All
What Makes Viking Therapeutics (VKTX) an Attractive Potential Opportunity?
ClearBridge Investments, an investment management company, released its “ClearBridge Small Cap Growth Strategy” first quarter 2024 investor letter. A copy of the letter can be downloaded here.
10 Best Weight Loss Drug Stocks to Buy Now
In this piece, we will take a look at the ten best weight loss drug stocks to buy now.
30 Biggest Biotechnology Companies in the World
In this article, we will be taking a look at the 30 biggest biotechnology companies in the world.
13 Best Booming Stocks to Buy Right Now
Despite latest data showing elevated inflation and a decline in retail sales, some major investment firms are looking beyond the short-term market turbulence and issuing highly positive outlook for the...
Viking Therapeutics, Inc. (NASDAQ:VKTX) Q4 2024 Earnings Call Transcript
Operator: Welcome to the Viking Therapeutics Fourth Quarter and Full Year 2023 Financial Results Conference Call. At this time, all participants are in a listen-only mode.
Viking Therapeutics, Inc. (NASDAQ:VKTX) Q3 2023 Earnings Call Transcript
Operator: Welcome to the Viking Therapeutics Third Quarter 2023 Financial Results Conference Call. At this time, all participants are in a listen-only mode.
15 Most Shorted Stocks That Are Loved By Analysts
In this piece, we will take a look at the 15 most shorted stocks that are loved by analysts.
5 Best Weight Loss Stocks To Invest In
In this article, we will be taking a look at the 5 best weight loss stocks to invest in.
15 Best-Performing Stocks in the Last 12 Months
The US stock market has been performing unusually well in 2023. The most recent catalyst came after the Federal Reserve’s fight against inflation started signs of bearing fruit.
Billionaire Hedge Funds
